97cd6394 eb96 4002 be63 a881ef16184c

Cognition Therapeutics Inc.

CogRx is a clinical-stage pharmaceutical company developing novel drugs that work through a completely new mechanism to treat or prevent Alzheimer's disease.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Pittsburgh, PA, USA
  • Currency USD
  • Founded August 2007
  • Employees 8
  • Incorporation Type C-corp
  • Website

Company Summary

Cognition Therapeutics (CogRx) is a clinical-stage small molecule therapeutics company focused on the discovery and development of novel drugs for neurodegenerative diseases. CogRx has discovered first-in-class therapeutics that selectively block soluble Aβ oligomers from causing cognitive decline. CogRx’s compounds work through a new neuronal Aβ oligomer receptor complex to reverse memory loss in Alzheimer's disease models.


  • Default avatar
    Franz Hefti
    Founder and Board Director

  • Default avatar
    Susan Catalano
    Chief Science Officer

    Scientific leadership positions at Roche, Rigel and Acumen
    Discovered Rigel’s Aurora kinase inhibitor R763
    17 yrs pharmaceutical discovery experience

  • Default avatar
    Hank Safferstein

    Worldwide Licensing and Marketing positions, Bristol-Myers Squibb
    Head of Corporate Development (3 early-stage biotechnology companies)
    19 yrs pharmaceutical experience
    Executive in Residence, Pittsburgh Life Science Greenhouse

  • Default avatar
    Gilbert Rishton
    Chemistry Advisor

    Founding medicinal chemist for Amgen’s small molecule chemistry effort
    Chemistry manager for Amgen’s Sensipar development program (preclinical and clinical)
    16 yrs pharmaceutical discovery experience

  • 21da825d a513 4cc2 980c 77a8e4e990be
    President and CEO

    President & CEO at Chimerix, Alteon, Biocyte
    Founder and VP at The Liposome Company
    Experience in venture capital, consulting (McKinsey) and investment banking


  • Default avatar
    Kate Shay at Duane Morris
    Default avatar
    Donnelly and Boland

Previous Investors

  • Default avatar
    Pittsburgh Life Sciences Greenhouse, Innovation Works
    Default avatar
    Ogden Capital, M5 Invest
    Default avatar
    Golden Seeds, Tech Coast Angels